The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.
Also called NCT05566028
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 172 participants
- Registry
-
NCT05566028
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05566028. Randomized; double masking; primary purpose treatment. Start 2022-10-12 (actual); primary completion 2024-01-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- D745 formulation I
- Intervention (Drug)
- D745 formulation II
- Intervention (Drug)
- D745 Placebo
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct05566028- Content hash
fc82da21715335383d186ba21f69e9ee534d903e22a49d7f2a1a296337069727